Sagimet Biosciences, Inc. Class A (SGMT) Stock Statistics & Valuation Metrics

Sagimet Biosciences, Inc. Class A has a market cap or net worth of $194.38M. The enterprise value is $106.13M.

Sagimet Biosciences, Inc. Class A has 31,001,108 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -34.92%.

The current PE Ratio of Sagimet Biosciences, Inc. Class A is ―. Sagimet Biosciences, Inc. Class A’s PEG ratio is 0.59.

In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of 0.00 and earned -45.57M in profits. Earnings per share was -1.45.

In the last 12 months, operating cash flow was -44.84M and capital expenditures 0.00, giving a free cash flow of -44.84M billion.

Sagimet Biosciences, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―

Sagimet Biosciences, Inc. Class A upcoming earnings date is Mar 30, 2026, After Close (Confirmed).

Sagimet Biosciences, Inc. Class A as a current ratio of 34.30, with Debt / Equity ratio of 0.10%

In the past 12 months, Sagimet Biosciences, Inc. Class A has paid 0.00 in taxes.

Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -1.43, with an EV/FCF ratio of -1.54.

Sagimet Biosciences, Inc. Class A has $116.69M in cash and marketable securities with $115.00K in debt, giving a net cash position of $116.58M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sagimet Biosciences, Inc. Class A is $28.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy